TITAN PHARMACEUTICALS INC Quarterly Current Ratio in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Titan Pharmaceuticals Inc quarterly Current Ratio history and growth rate from Q1 2012 to Q2 2024.
  • Titan Pharmaceuticals Inc Current Ratio for the quarter ending June 30, 2024 was 684 %, a 461% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 684 +562 +461% Jun 30, 2024
Q1 2024 438 +254 +138% Mar 31, 2024
Q4 2023 266 +0.37 +0.14% Dec 31, 2023
Q3 2023 180 -121 -40.2% Sep 30, 2023
Q2 2023 122 -234 -65.8% Jun 30, 2023
Q1 2023 184 -203 -52.4% Mar 31, 2023
Q4 2022 265 -102 -27.7% Dec 31, 2022
Q3 2022 300 -21.8 -6.77% Sep 30, 2022
Q2 2022 356 +125 +54.1% Jun 30, 2022
Q1 2022 387 +195 +102% Mar 31, 2022
Q4 2021 367 +187 +104% Dec 31, 2021
Q3 2021 322 +131 +68.6% Sep 30, 2021
Q2 2021 231 +28.5 +14.1% Jun 30, 2021
Q1 2021 192 +2.82 +1.49% Mar 31, 2021
Q4 2020 180 +7.77 +4.52% Dec 31, 2020
Q3 2020 191 -13.8 -6.72% Sep 30, 2020
Q2 2020 202 -71.4 -26.1% Jun 30, 2020
Q1 2020 189 -117 -38.2% Mar 31, 2020
Q4 2019 172 -142 -45.2% Dec 31, 2019
Q3 2019 205 -39.7 -16.3% Sep 30, 2019
Q2 2019 274 +19.9 +7.85% Jun 30, 2019
Q1 2019 305 -1.82 -0.59% Mar 31, 2019
Q4 2018 314 -78 -19.9% Dec 31, 2018
Q3 2018 244 -220 -47.4% Sep 30, 2018
Q2 2018 254 -138 -35.2% Jun 30, 2018
Q1 2018 307 -80.5 -20.8% Mar 31, 2018
Q4 2017 392 +57.8 +17.3% Dec 31, 2017
Q3 2017 465 +155 +50.1% Sep 30, 2017
Q2 2017 392 +93.3 +31.3% Jun 30, 2017
Q1 2017 388 +119 +44.1% Mar 31, 2017
Q4 2016 334 +37.5 +12.6% Dec 31, 2016
Q3 2016 309 +3.93 +1.29% Sep 30, 2016
Q2 2016 299 +36.4 +13.9% Jun 30, 2016
Q1 2016 269 +43.8 +19.4% Mar 31, 2016
Q4 2015 296 +107 +56.7% Dec 31, 2015
Q3 2015 306 +147 +92.2% Sep 30, 2015
Q2 2015 262 +117 +80.8% Jun 30, 2015
Q1 2015 225 +93.1 +70.4% Mar 31, 2015
Q4 2014 189 +69.3 +57.8% Dec 31, 2014
Q3 2014 159 +48.1 +43.3% Sep 30, 2014
Q2 2014 145 +38.5 +36.2% Jun 30, 2014
Q1 2014 132 +29.1 +28.3% Mar 31, 2014
Q4 2013 120 +18.4 +18.1% Dec 31, 2013
Q3 2013 111 -0.34 -0.31% Sep 30, 2013
Q2 2013 106 -12.7 -10.7% Jun 30, 2013
Q1 2013 103 -32.2 -23.8% Mar 31, 2013
Q4 2012 102 Dec 31, 2012
Q3 2012 111 Sep 30, 2012
Q2 2012 119 Jun 30, 2012
Q1 2012 135 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.